Detalles de la búsqueda
1.
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial.
Oncologist
; 28(10): 894-900, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315114
2.
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 20(10): 1386-1394, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31427205
3.
Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma.
Clin Genitourin Cancer
; 18(6): 429-435, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32800717
4.
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors.
J Clin Oncol
; 38(27): 3088-3094, 2020 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32491962
5.
Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario.
J Adv Pract Oncol
; 10(5): 483-493, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33457061
6.
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy.
J Immunother Cancer
; 7(1): 127, 2019 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31097024
7.
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors.
Clin Genitourin Cancer
; 17(3): 177-182, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30824360
8.
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab.
J Immunother Cancer
; 6(1): 107, 2018 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30333065
9.
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
Urol Oncol
; 36(10): 470.e19-470.e29, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30131292
10.
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma.
J Clin Oncol
; 35(16): 1764-1769, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28113029
Resultados
1 -
10
de 10
1
Próxima >
>>